About this Research Topic
Endothelial dysfunction is a not well-defined term, it is widely used to describe the non-physiologic activity of endothelial cells. It has been suggested that endothelial dysfunction plays a role in a variety of human diseases, such as arteriosclerosis, cancer, autoimmunity and sepsis. More recently, a role of lymphatic endothelial cells as well as vascular endothelial cells in the pathophysiology of inflammation and allo-immune reactions has been suggested. Development of novel therapeutic approaches to normalize endothelial dysfunction is currently an unmet medical need. Until now, the cellular and molecular mechanisms of mutual influences between endothelial dysfunction and human diseases remain largely unexplored, constituting a frontier hindering the development of new therapies.
This Research Topic aims to build a forum for a wide range of scientific studies in the fields of endothelial dysfunction during inflammatory diseases and transplantation. These include, but are not limited to:
• The interaction of endothelial cells with leukocytes during disease
• The role of angiogenesis and lymphangiogenesis in inflammation and allogeneic immune responses
• Mechanisms that lead to endothelial dysfunction
• Mechanisms how endothelial dysfunction impacts the pathophysiology of diseases
• Biomarkers and prognostic parameters related to the endothelium
• Therapeutic approaches to influence endothelial dysfunction
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.